- Filed
- Aug 24, 2017 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2017 · Aug 21, 2017 | 51.42M sh |
| Long Term Debt | Q2 2017 · Jul 31, 2017 | $1.18B |
| Long Term Debt | Q2 2017 · Jan 31, 2017 | $1.18B |
| Stockholders Equity | Q2 2017 · Jul 31, 2017 | $2.28B |
| Stockholders Equity | Q2 2017 · Jan 31, 2017 | $2.22B |
| Stockholders Equity restated | Q2 2017 · Jul 31, 2016 | $2.22B |
| Current Liabilities | Q2 2017 · Jul 31, 2017 | $279.2M |
| Current Liabilities | Q2 2017 · Jan 31, 2017 | $257.1M |
| Current Assets | Q2 2017 · Jul 31, 2017 | $2.03B |
| Current Assets | Q2 2017 · Jan 31, 2017 | $1.96B |
| Total Assets | Q2 2017 · Jul 31, 2017 | $3.79B |
| Total Assets | Q2 2017 · Jan 31, 2017 | $3.7B |
| Shares Diluted | Q2 2017 · Jul 31, 2016 | 52.2M sh |
| Shares Diluted | Q2 2017 · Jul 31, 2016 | 52.2M sh |
| Stock Repurchased | Q2 2017 · Jul 31, 2016 | $8.8M |
| Capex | Q2 2017 · Jul 31, 2016 | $6.1M |
| Capex | Q2 2017 · Jul 31, 2016 | $25.3M |
| Operating Cash Flow | Q2 2017 · Jul 31, 2016 | $77.4M |
| Cash And Equivalents | Q2 2017 · Jul 31, 2016 | $250.4M |
| Cash And Equivalents | Q2 2017 · Jan 31, 2016 | $427.8M |
| Eps Diluted restated | Q2 2017 · Jul 31, 2016 | $0.15 |
| Eps Diluted restated | Q2 2017 · Jul 31, 2016 | $0.20 |
| Eps Basic restated | Q2 2017 · Jul 31, 2016 | $0.15 |
| Eps Basic restated | Q2 2017 · Jul 31, 2016 | $0.20 |
| Sga Expense | Q2 2017 · Jul 31, 2016 | $60.1M |
| Sga Expense restated | Q2 2017 · Jul 31, 2016 | $120.4M |
| Net Income restated | Q2 2017 · Jul 31, 2016 | $8M |
| Net Income restated | Q2 2017 · Jul 31, 2016 | $10.5M |
| Operating Income restated | Q2 2017 · Jul 31, 2016 | $55.6M |
| Cost Of Revenue restated | Q2 2017 · Jul 31, 2016 | $286.4M |
| Cost Of Revenue restated | Q2 2017 · Jul 31, 2016 | $555.7M |
| Revenue restated | Q2 2017 · Jul 31, 2016 | $731.7M |